The result that VEGF-A is a pivotal factor in the angiogenic switch was further confirmed with an islet beta cell-specific knockout of VEGF-A in RIP1-Tag2 mice, which impaired both angiogenic switching and subsequent tumor growth [525]. The gene discussed is VEGFA; the disease is neoplasm.